A Study of EVOLVE104 in People With Solid Tumor Cancer

Full Title

A Phase 1 Dose-Escalation and Expansion Study Evaluating the Safety, Efficacy, and Pharmacokinetics of EVOLVE104 in Subjects with Advanced Urothelial and Squamous Cell Carcinomas

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Gopakumar Iyer’s office at 646-888-4737.

Protocol
26-041
Phase
Phase I (phase 1)
Disease Status
Relapsed or Refractory
Investigator
Gopa Iyer
Co-Investigators
Ezra Rosen
Diseases
Squamous Cell Carcinoma
Upper Gastrointestinal › Esophageal Cancer
Locations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau
ClinicalTrials.gov ID
NCT07217171
ClinicalTrials.gov
Visit ClinicalTrials.gov for full clinical trial description